When assessing risk for coronary artery disease, excess stomach fat represents the greatest indicator, not overall body mass index, according to a new study.
Central obesity assessed by waist circumference (WC) was associated with obstructive coronary artery disease (CAD) in postmenopausal women, while overall body mass index (BMI) was not, according to a study published last week in Menopause, the journal of The North American Menopause Society.
In the study, researchers sought to investigate the association between obesity type and obstructive CAD. A total of 659 women aged older than 55 years with chest pain undergoing invasive coronary angiography in suspicion of CAD were studied. Obesity is measured through 2 assessments, BMI and WC, but prior studies have not confirmed which type of obesity is more significant in the development of CAD.
Data was derived from the prospective and nationwide registry database Korean Women’s Chest Pain Registry, which assesses the clinical characteristics and outcomes of CAD in Korean women. The angiographic findings were utilized to define obesity levels in these women:
Research revealed that 311 (47.2%) women in the study had obstructive CAD. When measuring for incidence and BMI in participants with and without obstructive CAD, there was no significant difference in overall obesity (44.6% vs 48.5%; P = .340) or BMI (P = .373). Women with central obesity, however, exhibited a significantly higher prevalence of CAD than those without (55% vs 41%; P = .001). After conducting a multivariable analysis, central obesity was associated with obstructive CAD (odds ratio=1.61; 95% CI, 1.10-2.34; P = .013), while overall obesity was not (P = .228).
Stephanie Faubion, MD, NAMS medical director, in a statement highlighted the stark difference of fat distribution found in the study in association to CAD risk. “The findings of the study are consistent with what we know about the detrimental effects of central obesity. Not all fat is the same, and central obesity is particularly dangerous because it is associated with risk for heart disease, the number 1 killer of women,” he said.
Central obesity has been shown in the past to be more indicative of health issues, with an article posted last month correlating postmenopausal women with normal-weight central obesity to a heightened risk of mortality, cardiovascular disease, and cancer. As mentioned in the article, normal-weight women who revealed no risk in the BMI assessment were shown to exhibit significant risk of mortality for these diseases, which highlights the importance of utilizing WC.
While associations between WC and CAD were found in the study, the findings do have limitations. Researchers considered women over the age of 55 to be postmenopausal, but there is a possibility that some Korean women were still premenopausal. The additional focus solely on Korean women restricts associations to this group, which may not be applicable to other populations. Cross-sectional analysis also could not confirm a causal relationship between obesity and CAD, which warrants further investigation.
“Identifying women with excess abdominal fat, even with a normal BMI, is important so that lifestyle interventions can be implemented,” said Faubion.
Reference
Cho JH, Kim HL, Kim MA, et al. Association between obesity type and obstructive coronary artery disease in stable symptomatic postmenopausal women. [published online August 28, 2019]. Menopause. doi: 10.1097/GME.0000000000001392.
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
The HHS Office for Civil Rights is investigating whether patient data were exposed in the cyberattack on Change Healthcare; a new study claims that the US’ high maternal mortality rates are the product of flawed data; HHS secretary is open to drug testing recipients of welfare.
Read More